Skip to main content
. 2016 Jul 13;16:462. doi: 10.1186/s12885-016-2536-2

Fig. 5.

Fig. 5

Cell-based Reovirus vaccine for the treatment of established tumours. Survival of (a) B16F10 and (b) LLC-bearing mice subsequent to treatment with a single dose of cell-based vaccine. Tumour volume of same groups, (c) B16F10 and (d) LLC, showing a significant delay in tumour development in treated mice